MANA Advisors’s Bristol-Myers Squibb BMY Stock Holding History

MANA Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,598	Closed	-$329K	–	102
2020 Q2	$329K	Buy	+5,598	New	+$335K	1.42%	17
2019 Q2	–	Sell	-4,993	Closed	-$238K	–	165
2019 Q1	$238K	Buy	+4,993	New	+$249K	0.77%	64
2018 Q2	–	Sell	-3,488	Closed	-$221K	–	84
2018 Q1	$221K	Sell	3,488 -16,622	-83%	-$1.07M	0.32%	166
2017 Q4	$1.23M	Buy	+20,110	New	+$1.26M	0.53%	45

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

MANA Advisors's BMY Position: Q3 2020 in Review

MANA Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 5,598 shares — an estimated $329K sold.

MANA Advisors first reported a position in BMY in Q4 2017 and held it in 4 quarters. The position peaked at $1.23M in Q4 2017. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

MANA Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
MANA Advisors sold 5,598 Bristol-Myers Squibb shares in Q3 2020, an estimated $329K.
MANA Advisors first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 4 quarters.
MANA Advisors's Bristol-Myers Squibb position peaked at $1.23M in Q4 2017.
2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on MANA Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.